News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Opportunistic infections
MRSA in the Groin of HIV Patients Ups Infection Risk

Colonization of methicillin-resistant Staphylococcus aureus (MRSA) in the groin area of HIV-infected adults increases risk for subsequent clinical infection, according to results of a prospective study carried out by the Centers for Disease Control and Prevention.

Published
14 March 2013
From
Medscape (requires registration)
HIV treatment in children
Lopinavir/ritonavir equivalent to nevirapine in Ugandan children

A ritonavir-boosted lopinavir (LPV/r)-based regimen achieved a comparable rate of virologic suppression when compared to a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen in HIV-infected Ugandan children at 48

Published
14 March 2013
By
Carole Leach-Lemens
HIV and criminal law
Germany: National AIDS Council releases powerful policy statement on HIV criminalisation

The German National AIDS Council – an independent advisory body of the Ministry of Health consisting of experts from the fields of research, medical care, public health services, ethics, law, social sciences, as well as people from the civil society – has produced a consensus statement on HIV criminalisation during consensual sex.

Published
14 March 2013
From
HIV Justice Network
Resistance
Computer models predict how patients will respond to HIV drugs

Results of a new study demonstrate that computer models can predict how HIV patients whose drug therapy is failing will respond to a new treatment. Crucially for patients in poorer countries, the models do not require the results of expensive drug resistance tests to make their predictions. The study also showed that the models were able to identify alternative drug combinations that were predicted to work in cases where the treatment used in the clinic had failed, suggesting that their use could avoid treatment failure.

Published
14 March 2013
From
Eurekalert Inf Dis
PEP
Postexposure Prophylaxis: Dealing With Old Guidelines

The patient responded, “With all due respect to the guidelines, in the current era when there are increasingly well-tolerated medications, why would you use a regimen that included only 2 NRTIs without a third drug in any setting where there is a risk of HIV transmission?”

Published
13 March 2013
From
Clinical Care Options (requires registration)
Lipodystrophy
Health Canada rejects tesamorelin for lipodystrophy

After consideration of the NDS, Health Canada decided that the risks of tesamorelin outweighed its benefits under the proposed conditions of use.

Published
13 March 2013
From
Theratechnologies press release
Neurological and cognitive problems
Over 10% in Older HIV Group Fit Alzheimer's Biomarker Risk Profile

Slightly more than 10% of older Australian patients with well-controlled HIV infection had cerebrospinal fluid (CSF) marker profiles consistent with Alzheimer's disease--a risk prevalence more than 10 times higher than in the general population at the same age.

Published
13 March 2013
From
NATAP
Testing policies and guidelines
Current HIV screening guidelines are too conservative

Two Northwestern University researchers report that the CDC's current HIV screening guidelines are too conservative and that more frequent testing would be cost-effective in the long run for both high- and low-risk groups. The researchers performed a mathematical modeling study to assess "optimal testing frequencies" for HIV screening in different risk groups. They concluded screening should be done up to every three months for the highest-risk individuals and low-risk groups should be tested every three years.

Published
13 March 2013
From
Eurekalert Inf Dis
HIV and criminal law
US: New toolkit for lawyers defending HIV-related prosecutions now available

A new toolkit from the Center for HIV Law and Policy / Positive Justice Project, released earlier this month, provides a wealth of information for lawyers representing people living with HIV who are facing criminal prosecution based on HIV status. … More →

Published
13 March 2013
From
HIV Justice Network
New and experimental hepatitis C treatment
Presidio Pharmaceuticals Announces Collaboration with Boehringer Ingelheim

The Parties to Initiate a Phase IIa Trial of an All-Oral Combination of Presidio’s HCV NS5A inhibitor (PPI-668) with Faldaprevir (BI201335) and BI207127 for the Treatment of Patients with Hepatitis C.

Published
13 March 2013
From
Presidio press release
← Prev1...56789...1427Next →

Filter by country